Skip to main content
Sign In


An Impressive Track Record


School of Medicine has a record of success and expertise in innovation, discovery and commercialization of therapies, drugs and medical devices. Our faculty members translate basic sciences into medical breakthroughs that help people around the world. 

Anschutz Medical Campus researchers, the bulk of whom work for the School of Medicine, attracted $420.3 million in grants in the 2014-15 fiscal year.


  • Researchers at the School of Medicine have designed mice that do not get fat when on a high-fat diet – a breakthrough that could address obesity in humans because humans have the same gene.
  • A CU Cancer Center study published in 2013 shows that bitter melon juice restricts pancreatic cancer cells from metabolizing glucose, thus cutting their energy source. 
  • School of Medicine professor Iñigo San Millán, PhD, is applying his research by working with the Colorado Buffaloes football team to improve player performance.
  • School of Medicine research, published in 2013,  found that dietary supplements of choline – a nutrient in liver, fish, nuts and eggs – during pregnancy lowers physiological risk factors of schizophrenia in infants. The first human liver transplant was performed by a surgical team from the CU School of Medicine.
  • School of Medicine researchers led the identification of child abuse with the publication in 1962 of their paper The Battered-Child Syndrome.
  • The “Visible Human Project,” a detailed, digital-image, 3-D representation of the human body, was led by the School of Medicine.

Research Newsroom


Polio-Like Illness Mainly Strikes Children

CU researchers are studying an enterovirus that may be related to a mysterious polio-like disease that has been affecting Americans, mainly children.

Infants and Food Allergies

If your infant is at-risk of developing peanut or egg allergies, a CU physician recommends talking to a doctor before introducing food that could trigger an allergic reaction.

Children's Hospital Joins Consortium

Children's Hospital Colorado will share research and resources around genomic medicine to speed improvements in treating disease.

Challenges to Medical Marijuana Research

Studies of marijuana use to treat inflammatory bowel disease are hampered by a lack of scientific evidence, public perception of the drug’s safety and legal prohibitions making it difficult to design research studies.

Can RA Be Stopped

A CU research trial is investigating whether medication given before rheumatoid arthritis sets in can prevent the disease's progression.

First Colorado Marijuana Trials

The first marijuana studies sponsored by the state of Colorado are investigating the drug's effect on Parkinson's and spine pain.

Pregnant Women Should Avoid Pot

Doctors say women should shun pot when pregnant because research about its effects is inconsistent and scant.

Grant to Screen Diabetes, Celiac

The CU Barbara Davis Center for Diabetes has been awarded a $1.2 million grant to develop the Autoimmunity Screening for Kids (ASK) Program.

Immunotherapy Fights Cancer

An experimental immunotherapy treatment is helping cancer patients at University of Colorado Hospital.

How to Avoid Hospital Readmission

There are ways to avoid being readmitted to a hospital including making an appointment after discharge with your primary care provider, a CU expert says.

Asthma Medicine Combo Is Safe

A CU research trial shows that a commonly used asthma drug combination is safe for children.

Healthy Gut Bacteria Lost in ICU

Healthy gut bacteria that can fight infection is lost within days of a patient entering ICU, a CU researcher says.

Reduce MS Costs

Neurologists offer five ways for patients with multiple sclerosis to reduce medical costs while enhancing the quality of their care.

Facial Size, Shape Research

Researchers have identified two significant genes associated with measures of human facial size and have identified 10 additional candidates for location of genes affecting human facial shape.

Grant for Neurological Research

CU researchers received an $800,000 grant to study neural communication that could help patients suffering from stroke, Parkinson's and other neurological conditions.